CIPHER PHARMACEUTICALS INC (CPH.CA) Forecast, Price Target & Analyst Ratings

TSX:CPH • CA17253X1050

Current stock price

18.65 CAD
+0.02 (+0.11%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CIPHER PHARMACEUTICALS INC (CPH.CA).

Forecast Snapshot

Consensus Price Target

Price Target
CA$19.92
+ 6.83% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
$0.14
Revenue Estimate
12.309M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
77.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
CA$19.92
Upside
+ 6.83%
From current price of CA$18.65 to mean target of CA$19.92, Based on 8 analyst forecasts
Low
CA$18.79
Median
CA$19.38
High
CA$22.05

Price Target Revisions

1 Month
1.74%
3 Months
8.37%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for CPH.CA. The average price target is 19.92 CAD. This implies a price increase of 6.83% is expected in the next year compared to the current price of 18.65.
The average price target has been revised upward by 8.37% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CPH Current Analyst RatingCPH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

CPH Historical Analyst RatingsCPH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
77.50%
CPH.CA was analyzed by 8 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CPH.CA.
In the previous month the buy percentage consensus was at a similar level.
CPH.CA was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-03-23Leede Jones GabUpgrade Speculative Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
$0.14
Revenue Estimate
12.309M
Revenue Q2Q
2.41%
EPS Q2Q
36.35%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

CPH.CA is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is 0.14 CAD and the consensus revenue estimate is 12.31M CAD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
CPH.CA revenue by date.CPH.CA revenue by date.
20.68M
-5.74%		21.162M
2.33%		33.363M
57.66%		51.114M
53.21%		53.752M
5.16%		70.715M
31.56%		71.439M
1.02%
EBITDA
YoY % growth
CPH.CA ebitda by date.CPH.CA ebitda by date.
12.04M
-12.50%		11.26M
-6.48%		11.865M
5.37%		26.157M
120.46%		28.649M
9.53%		35.82M
25.03%		36.606M
2.19%
EBIT
YoY % growth
CPH.CA ebit by date.CPH.CA ebit by date.
11.05M
-15.39%		10.033M
-9.20%		7.848M
-21.78%		17.169M
118.77%		22.126M
28.87%		N/AN/A
Operating Margin
CPH.CA operating margin by date.CPH.CA operating margin by date.
53.43%47.41%23.52%33.59%41.16%N/AN/A
EPS
YoY % growth
CPH.CA eps by date.CPH.CA eps by date.
N/A
14.03%		0.79
123.48%		0.46
-41.77%		0.70
126.09%		0.75
-27.65%		0.96
27.52%		1.00
4.21%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		0.14
36.35%		0.18
-19.66%		0.23
8.21%		0.19
-62.37%
Revenue
Q2Q % growth		12.309M
2.41%		13.594M
1.59%		14.073M
9.66%		13.271M
8.62%
EBITDA
Q2Q % growth		6.325M
47.23%		7.288M
-15.45%		7.933M
-23.72%		6.599M
11.24%
EBIT
Q2Q % growth		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CPH.CA Yearly Revenue VS EstimatesCPH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M
CPH.CA Yearly EPS VS EstimatesCPH.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 -1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-1.30%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
11.81%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
48.91%
EBIT Next 5 Year
35.54%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CIPHER PHARMACEUTICALS INC / CPH.CA Forecast FAQ

What is the average price target for CIPHER PHARMACEUTICALS INC (CPH.CA) stock?

8 analysts have analysed CPH.CA and the average price target is 19.92 CAD. This implies a price increase of 6.83% is expected in the next year compared to the current price of 18.65.

Can you provide the upcoming earnings date for CIPHER PHARMACEUTICALS INC?

CIPHER PHARMACEUTICALS INC (CPH.CA) will report earnings on 2026-05-07.

Can you provide the consensus estimates for CIPHER PHARMACEUTICALS INC next earnings?

The consensus EPS estimate for the next earnings of CIPHER PHARMACEUTICALS INC (CPH.CA) is 0.14 CAD and the consensus revenue estimate is 12.31M CAD.

What is the consensus rating for CPH stock?

The consensus rating for CIPHER PHARMACEUTICALS INC (CPH.CA) is 77.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.